Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, ...
Any practitioner who cares for patients with psoriasis should be familiar with and make use of systemic therapies. These medications are clearly indicated for patients who have diffuse disease where ...
While lobectomy is the surgical gold standard for early-stage NSCLC, some patients will continue to need pneumonectomy to achieve radical resection. Historically, the use of adjuvant and neoadjuvant ...
3d
FDA Approves Bristol Myers Squibb's Breyanzi As First CAR T Therapy For R/R Marginal Zone Lymphoma
Bristol Myers Squibb (BMY) announced that the U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen ...
Oligometastatic renal cell carcinoma (OM-RCC) refers to patients who have limited (typically up to 5) metastatic lesions. Although management principles may overlap, OM-RCC is distinguishable from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback